News Coverage 08.05.19 By: John Carroll Share on Twitter Share on Facebook Share on LinkedIn Close to a decade after Eli Lilly killed it, Jeffrey Bluestone’s ‘breakthrough’ drug is back and being steered to the FDA Related Announcement, From Bench to Fireside Episode Eight: Robbie Majzner, MD Announcement, From Bench to Fireside Episode Seven: Evanna Mills, PhD Announcement, From Bench to Fireside Episode Six: Justin Eyquem, PhD